Professor, Medicine, Indiana University School of Medicine
Infectious Disease
Dr. Kenneth H. Fife, MD
|
|
Give Review
Doctor Kenneth H. Fife, MD practices Infectious Disease. He attended Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a one of the best medicals schools. Johns Hopkins University School of Medicine has a rank of 3 in research and a 29 in primary care Kenneth Fife is a published doctor and has 102 publications published. The lastest was: 'Human papillomavirus vaccine development.' Kenneth Fife accepts all Medicare patients.
Publications
- Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples.
- Host genetic and viral determinants of HIV-1 RNA set-point among HIV-1 seroconverters from sub-Saharan Africa.
- Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-...
- Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.
- HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.
- Helicase-primase inhibitor pritelivir for HSV-2 infection.
- Plasma viral loads during early HIV-1 infection are similar in subtype C- and non-subtype C-infected African seroconverters.
- Partner characteristics predicting HIV-1 setpoint in sexually acquired HIV-1 among African seroconverters.
- Outside Sexual Partnerships and Risk of HIV Acquisition for HIV Uninfected Partners in African HIV Serodiscordant Partnerships.
- Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.
- Bariatric surgery outcomes in HIV-infected subjects: a case series.
- Herpes Simplex Virus Type 2 Infection in Young Adult Women: Risk Factors for Infection and Frequency of Viral Shedding.
- Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic.
- Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.
- The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
- Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions.
- The Centers for Disease Control and Prevention revised recommendations for HIV testing: reactions of women attending community health clinics.
- A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir.
- Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo...
- Are the antiherpes nucleosides really all the same?
- Incidence and prevalence of herpes simplex virus infections in adolescent women.
- Herpes virus type 2 infection and genital symptoms in primary care patients.
- Predictors of herpes simplex virus type 2 antibody positivity among persons with no history of genital herpes.
- Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults.
- Return for results after herpes simplex virus type 2 screening.
- Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in men.
- Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
- Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.
- Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries.
- Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies.
- Once daily valacyclovir for reducing viral shedding in subjects newly diagnosed with genital herpes.
- An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagno...
- Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine.
- Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women.
- A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent...
- Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.
- Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial.
- Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
- External genital warts: diagnosis, treatment, and prevention.
- Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.
- Single-day famciclovir for the treatment of genital herpes: follow-up results of time to next recurrence and assessment of antiviral resistance.
- Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons.
- Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
- Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive ...
- Acceptability of genital herpes immunization. The role of health beliefs and health behaviors.
- Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical t...
- Detection of multiple human papillomavirus types in condylomata acuminata from immunosuppressed patients.
- Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir Study Group.
- Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women.
- Primary and recurrent concomitant genital infection with herpes simplex virus types 1 and 2.
- Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: correlation with virus-like particle IgG concentration.
- Virus-like particles and E1-E4 protein expressed from the human papillomavirus type 11 bicistronic E1-E4-L1 transcript.
- Cytomorphologic correlates of human papillomavirus infection in the "normal" cervicovaginal smear.
- The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.
- Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS.
- The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection.
- Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients.
- Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy.
- Association of human papillomavirus type 11 DNA with squamous cell carcinoma of the tongue.
- Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir.
- Reinfection is an uncommon occurrence in patients with symptomatic recurrent genital herpes.
- High-grade dysplasia in genital warts from two patients infected with the human immunodeficiency virus.
- Human papillomavirus type 11 E1--E4 and L1 proteins colocalize in the mouse xenograft system at multiple time points.
- Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia.
- Temporal and histologic relationships of proliferating cell nuclear antigen and human papillomavirus type 11 in the mouse xenograft system.
- Nucleotide sequence and characterization of human papillomavirus type 83, a novel genital papillomavirus.
- Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period.
- A one-step method for detecting and typing human papillomavirus DNA in cervical scrape specimens from women with cervical dysplasia.
- Human papillomavirus detection by hybrid capture in paired cervicovaginal lavage and cervical biopsy specimens.
- Symptomatic and asymptomatic cervical infections with human papillomavirus during pregnancy.
- Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National In...
- Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
- Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy.
- Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae.
- Human papillomavirus vaccine development.
- Genital warts and their treatment.
- Stakeholders perception of HIV sero-discordant couples in western Kenya.
- Determinants in HIV counselling and testing in couples in North Rift Kenya.
- The intracellular expression pattern of the human papillomavirus type 11 E1--E4 protein correlates with its ability to self associate.
- The human papillomavirus type 11 E1E4 protein is phosphorylated in genital epithelium.
- Differences among mononuclear cell subpopulations in HIV seropositive or seronegative homosexual and heterosexual men as determined by four-color flow cytometry.
- Human papillomavirus infections of the genital tract.
- Functional characterization of the C---C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2.
- Expression of the human papillomavirus type 11 E5A protein from the E1E4,E5 transcript.
- Incidence of HIV infection in monocyte subpopulations characterized by CD4 and HLA-DR surface density.
- Intravenous acyclovir for the treatment of primary genital herpes.
- Analysis of human papillomavirus types in exophytic condylomata acuminata by hybrid capture and Southern blot techniques.
- New treatments for genital warts less than ideal: abstract and commentary.
- Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients.
- Clinical misidentification of patients with first episode genital herpes: a note of caution.
- Lack of evidence for intertypic recombinants in the pathogenesis of recurrent genital infections with herpes simplex virus type 1.
- Human papillomavirus type 6 long control region and human cellular DNA contain related sequences.
- Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Tr...
- Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi''s sarcoma.
- Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial.
- A human papillomavirus related to human papillomavirus MM7/LVX82 produces distinct histological abnormalities in human foreskin implants grown as athymic mouse xenogra...
- Disseminated neonatal herpes simplex virus type 1 from a maternal breast lesion.
- Growth of molluscum contagiosum virus in a human foreskin xenograft model.
- Photo quiz. Cutaneous larva migrans.
- Over-the-counter acyclovir. An idea whose time has come.
- Human Papillomavirus DNA Detection in Older Women-Implications for Cancer Screening and Prevention.
Schools
Johns Hopkins University School of Medicine
Johns Hopkins Hospital
University Wash Hosps
Doctors Specialties
- Internal Medicine
- Infectious Disease
Accepted Insurances
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Drug Facts
| NPI NUMBER | 1497711865 | |
| NPPES Provider LastName | FIFE | |
| NPPES Provider FirstName | KENNETH | |
| NPPES Provider ZIPCode | 462025112 | |
| NPPES Provider State | IN | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 506.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497711865 |
| Last Name Of The Provider | FIFE |
| First Name Of The Provider | KENNETH |
| View All |
Similar Doctors
|
|
Dr. Richard B. Kohler, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicolas C. Knauss, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily J. Gropp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Upasana Jarori, MD |
|
|
Dr. Tina C. Fleming, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ayman Hallab, MD |
|
|
Dr. Douglas K. Kelsey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bradley L. Allen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen S. Israel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eva W. Muloma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William M. Hughes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leah K. Gehring, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary Birch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracey R. Ikerd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy B. Kressel, MD
This Doctor is OpenDoctor Recommended.
|